Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zomedica Corp ZOM

Healthcare Medical Devices
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic... see more

Recent & Breaking News (NYSEAM:ZOM)

Zomedica Announces Completion of $2.5 Million Registered Direct Offering

GlobeNewswire February 14, 2020

Zomedica Announces $2.5 Million Registered Direct Offering

GlobeNewswire February 12, 2020

Zomedica Files U.S. Patent Application for Fecal Parasite Detection

GlobeNewswire February 11, 2020

Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020

GlobeNewswire January 30, 2020

Zomedica to Focus on TRUFORMA(TM) Commercialization

GlobeNewswire January 23, 2020

Zomedica Successfully Completes Development and Manufacturing Milestones for its Cancer Liquid Biopsy Platform

GlobeNewswire January 20, 2020

Zomedica Announces Management Changes

GlobeNewswire December 3, 2019

Zomedica Expands ZM-006 Pilot Efficacy Study

GlobeNewswire November 13, 2019

Zomedica Announces Third Quarter 2019 Financial Results

GlobeNewswire November 12, 2019

Zomedica Announces 2019 Annual Meeting Results

GlobeNewswire November 5, 2019

Zomedica Commences Final TRUFORMA(TM) Diagnostic Verification Study

GlobeNewswire October 31, 2019

CORRECTION FROM SOURCE: Zomedica Pushes TRUFORMA(TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market

Newsfile October 3, 2019

Zomedica Pushes TRUFORM (TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market

Newsfile October 1, 2019

PCG Research Announces Publication of Report Covering Zomedica Pharmaceuticals Corp.

Newsfile September 11, 2019

Zomedica to Present at the Fall Investor Summit on Monday, September 16 in New York City

Accesswire September 11, 2019

Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference

GlobeNewswire September 3, 2019

Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors

GlobeNewswire August 19, 2019

Zomedica Inc. Prepares to Launch Veterinarian Diagnostic Device, TRUFORMA(TM); Has Potential to Change Diagnostic Landscape in Animal Health (NYSE American: ZOM)

Accesswire August 13, 2019

Zomedica Announces Second Quarter 2019 Financial Results

GlobeNewswire August 8, 2019

Zomedica Announces TRUFORMAâ„¢ Assay Updates and R&D Expansion

GlobeNewswire August 7, 2019